NCT07567729

Brief Summary

This study will use brain wave information, known as electroencephalography (EEG), to help guide anesthesia delivery during surgery. It is believed that the use of EEG has the potential to reduce postoperative delirium - a common side effect of general anesthesia. Postoperative delirium is known to cause long lasting cognitive deficits and increase the chance of developing dementia in geriatric patients. This study aims to reduce these risks posed by modern day anesthesia practices through more efficient delivery of anesthesia utilizing brain wave activity information.

Trial Health

65
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
225

participants targeted

Target at P75+ for not_applicable

Timeline
56mo left

Started Jun 2026

Longer than P75 for not_applicable

Status
not yet recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

April 24, 2026

Completed
11 days until next milestone

First Posted

Study publicly available on registry

May 5, 2026

Completed
27 days until next milestone

Study Start

First participant enrolled

June 1, 2026

Expected
2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 1, 2028

2.6 years until next milestone

Study Completion

Last participant's last visit for all outcomes

January 1, 2031

Last Updated

May 5, 2026

Status Verified

April 1, 2026

Enrollment Period

2 years

First QC Date

April 24, 2026

Last Update Submit

April 30, 2026

Conditions

Outcome Measures

Primary Outcomes (1)

  • Minimum Alveolar Concentration (MAC)

    The primary endpoint is the total intraoperative anesthetic exposure. This will be measured as the time-weighted average of the age-adjusted Minimum Alveolar Concentration (MAC) of volatile anesthetic administered during the maintenance phase of anesthesia. These data will be collected directly from the electronic anesthetic record for each enrolled patient case and will be reviewed and verified by the study team.

    Intra-operative phase of care of participant.

Secondary Outcomes (1)

  • 3-Minute Diagnostic Confusion Assessment Method (3D-CAM)

    Postoperative Days 1 to 3.

Study Arms (3)

Part A: Anesthesia Providers that Receive Training

ACTIVE COMPARATOR

Eligible anesthesia providers that include both anesthesiologists and CRNAs who will receive an EEG-guided anesthesia training program for anesthesia providers.

Other: EEG-guided anesthesia training program for anesthesia providers

Part A: Anesthesia Providers that Do Not Receive Training

NO INTERVENTION

Eligible anesthesia providers that include both anesthesiologists and CRNAs who will did not receive an EEG-guided anesthesia training program for anesthesia providers.

Part B: All Participants Receive the EEG-Guided Intervention

OTHER

Part B will be a prospective, single-arm pilot study. As a result, randomization of patients into different groups will not occur, and all patients will receive the EEG-guided intervention. Blinding of the intraoperative clinical team is also not feasible in this case, as providers must be aware of all monitoring tools in use. Instead, this study will mitigate potential for bias by utilizing blinded outcome assessors. Researchers will be kept separate from the intraoperative care team to remain unaware of specific details of the patient's anesthetic course.

Device: EEG-Guided Intervention

Interventions

The EEG-guided anesthesia training session for the anesthesia providers will administer simulation-based assessments at baseline, immediately post-intervention, and at one, three, and six month follow-up time points to track provider competency in EEG interpretation and anesthetic titration.

Part A: Anesthesia Providers that Receive Training

All surgical patients in Part B of the study will receive EEG-guided anesthesia. EEG data collected from patient participants will be provided as live data during their surgical procedures to the anesthesia provider. Anesthesia providers may use this data to assist their decision-making on anesthetic delivery.

Part B: All Participants Receive the EEG-Guided Intervention

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Signed and dated informed consent form prior to any study-specific procedures.
  • Willingness and ability to comply with all study procedures and availability for the duration of the study, including all scheduled assessments and follow-up visits.
  • Currently practicing anesthetic provider, defined as either:
  • Attending anesthesiologist, or
  • Certified Registered Nurse Anesthetist (CRNA).

You may not qualify if:

  • Fluent in English, to ensure comprehension of study materials and assessments.
  • Able to access and utilize required technology (e.g., computer or tablet with internet access) for completion of digital modules and online assessments.
  • In good general health and capable of fulfilling clinical duties, as self-reported and confirmed by site investigator review.
  • Willingness to be randomized to any of the study arms and to participate in all assigned educational interventions and assessments.
  • Willingness to adhere to the protocol-specified anesthetic management strategy during the real-case assessments.
  • Provides written, signed informed consent prior to the surgical procedure.
  • Is age 60 years or older.
  • Is scheduled to undergo an elective, non-cardiac, non-neurologic surgical procedure expected to last at least two hours.
  • Is planned to receive general anesthesia.
  • Has an American Society of Anesthesiologists (ASA) physical status of I, II, or III.
  • Has intact skin on the forehead suitable for the application of EEG electrodes.
  • Fellowship training in neuroanesthesia or neurocritical care.
  • Participation in EEG-related research or formal EEG training within the past 12 months.
  • Inability to access or utilize required technology (e.g., computer or tablet with internet access) necessary for completion of digital modules and online assessments.
  • Any condition (physical, psychological, or cognitive) that, in the opinion of the site investigator, would preclude full participation in study activities or completion of the study protocol.
  • +9 more criteria

Contact the study team to confirm eligibility.

Sponsors & Collaborators

MeSH Terms

Conditions

Emergence Delirium

Condition Hierarchy (Ancestors)

DeliriumConfusionNeurobehavioral ManifestationsNeurologic ManifestationsNervous System DiseasesPostoperative ComplicationsPathologic ProcessesPathological Conditions, Signs and SymptomsSigns and SymptomsNeurocognitive DisordersMental Disorders

Central Study Contacts

Maya Clinical Research Coordinator Associate

CONTACT

Ariel Clinical Research Coordinator Associate

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Purpose
PREVENTION
Intervention Model
PARALLEL
Model Details: In Part A, researchers will be identifying eligible anesthesia providers that include both anesthesiologists and CRNAs via institutional rosters at Stanford Medical Center. Once enrollment is complete, an independent statistician will begin the randomization of participants into the intervention (training) or control (no training) groups using "computer-generated sequence stratified by participant years (\<10 years, 10-30 years, \>30 years) to ensure balanced allocation. Part B will be a prospective, single-arm pilot study. As a result, randomization of patients into different groups will not occur, and all patients will receive the EEG-guided intervention. Blinding of the intraoperative clinical team is also not feasible in this case, as providers must be aware of all monitoring tools in use. Instead, this study will mitigate potential for bias by utilizing blinded outcome assessors. Researchers will be kept separate from the intraoperative care team.
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
MD

Study Record Dates

First Submitted

April 24, 2026

First Posted

May 5, 2026

Study Start (Estimated)

June 1, 2026

Primary Completion (Estimated)

June 1, 2028

Study Completion (Estimated)

January 1, 2031

Last Updated

May 5, 2026

Record last verified: 2026-04